610 related articles for article (PubMed ID: 24300213)
1. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.
Zhang C; Chen J; Feng C; Shao X; Liu Q; Zhang Q; Pang Z; Jiang X
Int J Pharm; 2014 Jan; 461(1-2):192-202. PubMed ID: 24300213
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.
Feng C; Zhang C; Shao X; Liu Q; Qian Y; Feng L; Chen J; Zha Y; Zhang Q; Jiang X
Int J Pharm; 2012 Feb; 423(2):226-34. PubMed ID: 22193058
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
[TBL] [Abstract][Full Text] [Related]
4. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations.
Chen J; Zhang C; Liu Q; Shao X; Feng C; Shen Y; Zhang Q; Jiang X
J Drug Target; 2012 Feb; 20(2):174-84. PubMed ID: 21992548
[TBL] [Abstract][Full Text] [Related]
5. The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.
Zhang C; Zheng X; Wan X; Shao X; Liu Q; Zhang Z; Zhang Q
J Control Release; 2014 Oct; 192():317-24. PubMed ID: 25102404
[TBL] [Abstract][Full Text] [Related]
6. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration.
Wen Z; Yan Z; He R; Pang Z; Guo L; Qian Y; Jiang X; Fang L
Drug Deliv; 2011 Nov; 18(8):555-61. PubMed ID: 21812752
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid (PEG-PLGA) nanoparticles for the treatment of schizophrenia.
Piazza J; Hoare T; Molinaro L; Terpstra K; Bhandari J; Selvaganapathy PR; Gupta B; Mishra RK
Eur J Pharm Biopharm; 2014 May; 87(1):30-9. PubMed ID: 24560967
[TBL] [Abstract][Full Text] [Related]
8. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
[TBL] [Abstract][Full Text] [Related]
9. Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer's Disease.
Zheng X; Shao X; Zhang C; Tan Y; Liu Q; Wan X; Zhang Q; Xu S; Jiang X
Pharm Res; 2015 Dec; 32(12):3837-49. PubMed ID: 26113236
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.
Xia H; Gao X; Gu G; Liu Z; Zeng N; Hu Q; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H
Biomaterials; 2011 Dec; 32(36):9888-98. PubMed ID: 21937105
[TBL] [Abstract][Full Text] [Related]
11. SUN11602 has basic fibroblast growth factor-like activity and attenuates neuronal damage and cognitive deficits in a rat model of Alzheimer's disease induced by amyloid β and excitatory amino acids.
Ogino R; Murayama N; Noshita T; Takemoto N; Toba T; Oka T; Narii N; Yoshida S; Ueno N; Inoue T
Brain Res; 2014 Oct; 1585():159-66. PubMed ID: 25130662
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model.
Zhao YZ; Lin M; Lin Q; Yang W; Yu XC; Tian FR; Mao KL; Yang JJ; Lu CT; Wong HL
J Control Release; 2016 Feb; 224():165-175. PubMed ID: 26774220
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
14. Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides.
Li J; Zhang C; Li J; Fan L; Jiang X; Chen J; Pang Z; Zhang Q
Pharm Res; 2013 Jul; 30(7):1813-23. PubMed ID: 23549751
[TBL] [Abstract][Full Text] [Related]
15. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
Zameer S; Ali J; Vohora D; Najmi AK; Akhtar M
J Drug Target; 2021 Feb; 29(2):199-216. PubMed ID: 32876502
[TBL] [Abstract][Full Text] [Related]
16. UEA I-bearing nanoparticles for brain delivery following intranasal administration.
Gao X; Chen J; Tao W; Zhu J; Zhang Q; Chen H; Jiang X
Int J Pharm; 2007 Aug; 340(1-2):207-15. PubMed ID: 17499948
[TBL] [Abstract][Full Text] [Related]
17. B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide.
Liu Z; Gao X; Kang T; Jiang M; Miao D; Gu G; Hu Q; Song Q; Yao L; Tu Y; Chen H; Jiang X; Chen J
Bioconjug Chem; 2013 Jun; 24(6):997-1007. PubMed ID: 23718945
[TBL] [Abstract][Full Text] [Related]
18. A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-β₂₅₋₃₅-treated rats following intranasal administration.
Wu H; Li J; Zhang Q; Yan X; Guo L; Gao X; Qiu M; Jiang X; Lai R; Chen H
Eur J Pharm Biopharm; 2012 Feb; 80(2):368-78. PubMed ID: 22061263
[TBL] [Abstract][Full Text] [Related]
19. In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain.
Liu Q; Shao X; Chen J; Shen Y; Feng C; Gao X; Zhao Y; Li J; Zhang Q; Jiang X
Toxicol Appl Pharmacol; 2011 Feb; 251(1):79-84. PubMed ID: 21163285
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of huperzine A nasal in situ gel and evaluation of its brain targeting following intranasal administration].
Tao T; Zhao Y; Yue P; Dong WX; Chen QH
Yao Xue Xue Bao; 2006 Nov; 41(11):1104-10. PubMed ID: 17262956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
